Psyence Biomedical Ltd.Psyence Biomedical Ltd.Psyence Biomedical Ltd.

Psyence Biomedical Ltd.

No trades
See on Supercharts
Market capitalization
‪13.79 M‬USD
−0.03USD
‪8.01 M‬USD
‪4.70 M‬
Beta (1Y)
−1.33

About Psyence Biomedical Ltd.

CEO
Neil Maresky
Headquarters
Toronto
Employees (FY)
3
Founded
2023
FIGI
BBG01L71H227
Psyence Biomedical Ltd. is a life science biotechnology company. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company was founded on June 29, 2023 and is headquartered in Toronto, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of PBM is 1.06 USD — it has increased by 2.91% in the past 24 hours. Watch Psyence Biomedical Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Psyence Biomedical Ltd. stocks are traded under the ticker PBM.
PBM stock is 11.04% volatile and has beta coefficient of −1.33. Track Psyence Biomedical Ltd. stock price on the chart and check out the list of the most volatile stocks — is Psyence Biomedical Ltd. there?
Yes, you can track Psyence Biomedical Ltd. financials in yearly and quarterly reports right on TradingView.
PBM stock has risen by 13.98% compared to the previous week, the month change is a 4.95% rise, over the last year Psyence Biomedical Ltd. has showed a 90.08% decrease.
PBM net income for the last quarter is ‪−647.77 K‬ USD, while the quarter before that showed ‪−62.84 K‬ USD of net income which accounts for −930.79% change. Track more Psyence Biomedical Ltd. financial stats to get the full picture.
Today Psyence Biomedical Ltd. has the market capitalization of ‪13.79 M‬, it has increased by 20.82% over the last week.
No, PBM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PBM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Psyence Biomedical Ltd. stock right from TradingView charts — choose your broker and connect to your account.
PBM reached its all-time high on Nov 22, 2023 with the price of 14.55 USD, and its all-time low was 0.51 USD and was reached on Feb 22, 2024. View more price dynamics on PBM chart.
See other stocks reaching their highest and lowest prices.
As of May 8, 2024, the company has 3.00 employees. See our rating of the largest employees — is Psyence Biomedical Ltd. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Psyence Biomedical Ltd. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Psyence Biomedical Ltd. stock shows the neutral signal. See more of Psyence Biomedical Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.